|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
HRP20130602T1
(en)
|
2003-07-30 |
2013-07-31 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
|
WO2006045096A2
(en)
*
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
|
|
WO2006063164A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Wisconsin Alumni Research Foundation |
Compositions and methods for treating neuroendocrine tumors
|
|
US8475776B2
(en)
*
|
2005-04-28 |
2013-07-02 |
Paloma Pharmaceuticals, Inc. |
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
|
|
USRE46558E1
(en)
|
2005-04-28 |
2017-09-26 |
Paloma Pharmaceuticals, Inc. |
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
|
|
US8026278B2
(en)
*
|
2005-05-27 |
2011-09-27 |
Smith Brian R |
Inhibitors of pyruvate kinase as therapeutic agents for cancer
|
|
CA2608367C
(en)
|
2005-06-08 |
2014-08-19 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US7576053B2
(en)
|
2005-06-13 |
2009-08-18 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
|
PT1734251E
(pt)
*
|
2005-06-17 |
2007-03-30 |
Magneti Marelli Powertrain Spa |
Injector de combustível
|
|
WO2007016525A2
(en)
|
2005-07-29 |
2007-02-08 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
ATE525374T1
(de)
|
2005-12-13 |
2011-10-15 |
Incyte Corp |
Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
|
|
EP1976976A4
(en)
*
|
2005-12-23 |
2010-12-15 |
Univ Rochester |
TREATMENT OF NEURO-AIDS USING INHIBITORS OF GLYCODY SYNTHASE KINASE (GSK) -3
|
|
ES2622493T3
(es)
|
2006-02-24 |
2017-07-06 |
Rigel Pharmaceuticals, Inc. |
Composiciones y métodos para la inhibición de la ruta de JAK
|
|
JP2009529047A
(ja)
|
2006-03-07 |
2009-08-13 |
アレイ バイオファーマ、インコーポレイテッド |
ヘテロ二環系ピラゾール化合物およびその使用
|
|
JP5137818B2
(ja)
|
2006-03-20 |
2013-02-06 |
生化学工業株式会社 |
関節リウマチの処置剤
|
|
EP2032538A2
(en)
*
|
2006-06-08 |
2009-03-11 |
Array Biopharma, Inc. |
Quinoline compounds and methods of use
|
|
US20080033045A1
(en)
*
|
2006-07-07 |
2008-02-07 |
Myriad Genetics, Incorporated |
Treatment of psychiatric disorders
|
|
JP5236664B2
(ja)
|
2007-02-01 |
2013-07-17 |
レスバーロジックス コーポレイション |
心血管疾患を予防および治療するための化合物
|
|
ES2467665T5
(es)
|
2007-06-13 |
2022-11-03 |
Incyte Holdings Corp |
Sales del inhibidor de cinasas Janus (R)-3-(4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciclopentilpropanonitrilo
|
|
AU2009214440B2
(en)
|
2008-02-15 |
2014-09-25 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
|
|
WO2009110415A1
(ja)
|
2008-03-03 |
2009-09-11 |
武田薬品工業株式会社 |
併用剤
|
|
WO2009111644A2
(en)
*
|
2008-03-05 |
2009-09-11 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating pancreatic cancer
|
|
US20110021618A1
(en)
*
|
2008-03-25 |
2011-01-27 |
Paloma Pharmaceuticals, Inc. |
Methods of treating fibrotic disorders
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
AU2009244897B2
(en)
|
2008-04-16 |
2014-11-13 |
Alexion Pharmaceuticals, Inc. |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
WO2009131687A2
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
NZ586440A
(en)
|
2008-06-26 |
2011-07-29 |
Resverlogix Corp |
Methods of preparing quinazolinone derivatives
|
|
WO2010011836A2
(en)
*
|
2008-07-25 |
2010-01-28 |
Emory University |
Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
|
|
AR073231A1
(es)
*
|
2008-08-29 |
2010-10-20 |
Genentech Inc |
Metodos diagnosticos y tratamientos para los tumores independientes del vegf (factor de crecimiento endotelial vascular)
|
|
WO2010075286A1
(en)
*
|
2008-12-24 |
2010-07-01 |
University Of Washington |
MOLECULAR ACTIVATORS OF THE Wnt/β-CATENIN PATHWAY
|
|
EP2660238B1
(en)
|
2009-01-08 |
2015-05-06 |
Resverlogix Corporation |
Compounds for the prevention and treatment of cardiovascular disease
|
|
WO2010093419A1
(en)
|
2009-02-11 |
2010-08-19 |
Merck Patent Gmbh |
Novel amino azaheterocyclic carboxamides
|
|
MX392179B
(es)
|
2009-03-18 |
2025-03-21 |
Resverlogix Corp |
Nuevos agentes anti-inflamatorios.
|
|
AU2010239266B2
(en)
|
2009-04-22 |
2015-01-22 |
Resverlogix Corp. |
Novel anti-inflammatory agents
|
|
JP6172939B2
(ja)
|
2009-05-22 |
2017-08-02 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ阻害薬としての３−［４−（７ｈ−ピロロ［２，３−ｄ］ピリミジン−４−イル）−１ｈ−ピラゾール−１−イル］オクタン−またはヘプタン−ニトリル
|
|
WO2010135650A1
(en)
|
2009-05-22 |
2010-11-25 |
Incyte Corporation |
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
|
|
AU2010281503B2
(en)
|
2009-08-07 |
2016-01-28 |
Merck Patent Gmbh |
Novel azaheterocyclic compounds
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
US8962627B2
(en)
|
2009-10-30 |
2015-02-24 |
Prestwick Chemical, Inc. |
Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
|
PE20130038A1
(es)
|
2010-03-10 |
2013-01-28 |
Incyte Corp |
Derivados de piperidin-4-il azetidina como inhibidores de jak1
|
|
KR102303885B1
(ko)
|
2010-05-21 |
2021-09-24 |
인사이트 홀딩스 코포레이션 |
Ｊａｋ 저해제에 대한 국소 제형
|
|
AU2011264917B2
(en)
|
2010-06-09 |
2015-08-06 |
Emory University |
TrkB agonists and methods of use
|
|
ES2729754T3
(es)
|
2010-07-29 |
2019-11-06 |
Merck Patent Gmbh |
Carboxamidas azaheterocíclicas de aminas cíclicas
|
|
UA110113C2
(xx)
|
2010-07-29 |
2015-11-25 |
|
Біциклічні азагетероциклічні карбоксаміди
|
|
EP2635557A2
(en)
|
2010-11-01 |
2013-09-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as jak kinase modulators
|
|
US9198911B2
(en)
|
2010-11-02 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
|
EA026201B1
(ru)
|
2010-11-19 |
2017-03-31 |
Инсайт Холдингс Корпорейшн |
Циклобутилзамещенные производные пирролопиридина и пирролопиримидина как ингибиторы jak
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
PL2643313T3
(pl)
|
2010-11-24 |
2017-03-31 |
Merck Patent Gmbh |
Azetydyny chinazolino-karboksyamidowe
|
|
US9381187B2
(en)
|
2011-02-16 |
2016-07-05 |
Paloma Pharmaceuticals, Inc. |
Radiation countermeasure agents
|
|
US9493436B2
(en)
|
2011-04-26 |
2016-11-15 |
Indiana University Research And Technology Corporation |
Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis
|
|
CA2839767A1
(en)
|
2011-06-20 |
2012-12-27 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
SG10201606301YA
(en)
|
2011-09-12 |
2016-09-29 |
Merck Patent Gmbh |
Novel imidazole amines as modulators of kinase activity
|
|
SI2755958T1
(sl)
|
2011-09-12 |
2017-12-29 |
Merck Patent Gmbh |
Aminopirimidinski derivati za uporabo kot modulatorji kinazne aktivnosti
|
|
PT2773354T
(pt)
|
2011-11-01 |
2019-07-17 |
Resverlogix Corp |
Formulações orais de libertação imediata para quinazolinonas substituídas
|
|
SG10201601352UA
(en)
|
2011-11-23 |
2016-03-30 |
Portola Pharm Inc |
Pyrazine kinase inhibitors
|
|
PT2794571T
(pt)
|
2011-12-22 |
2017-02-07 |
Merck Patent Gmbh |
Novas carboxamidas heterocíclicas como moduladores da atividade de quinase
|
|
AU2013207972B2
(en)
*
|
2012-01-10 |
2017-06-15 |
Nimbus Iris, Inc. |
IRAK inhibitors and uses thereof
|
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
|
EP2877461B1
(en)
|
2012-07-27 |
2018-05-09 |
Emory University |
Heterocyclic flavone derivatives, compositions, and methods related thereto
|
|
EP2903970A4
(en)
|
2012-10-08 |
2016-11-30 |
Portola Pharm Inc |
SUBSTITUTED PYRIMIDINYL KINASE INHIBITORS
|
|
RS62329B1
(sr)
|
2012-11-15 |
2021-10-29 |
Incyte Holdings Corp |
Dozni oblici ruksolitiniba sa produženim vremenom oslobađanja
|
|
US9580443B2
(en)
|
2012-11-16 |
2017-02-28 |
Merck Patent Gmbh |
Heterocyclic derivatives as modulators of kinase activity
|
|
ES2807539T3
(es)
|
2012-11-16 |
2021-02-23 |
Merck Patent Gmbh |
Derivados de imidazol-piperidinilo como moduladores de la actividad de quinasa
|
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
ES2821102T3
(es)
|
2012-11-29 |
2021-04-23 |
Merck Patent Gmbh |
Derivados de azaquinazolincarboxamida
|
|
EP2935253B1
(en)
|
2012-12-21 |
2018-08-01 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
TR201820520T4
(tr)
|
2013-03-06 |
2019-01-21 |
Incyte Holdings Corp |
Bir jak inhibitörü yapmaya yönelik prosesler ve ara ürünler.
|
|
US9458134B2
(en)
|
2013-03-11 |
2016-10-04 |
Merck Patent Gmbh |
Heterocycles as modulators of kinase activity
|
|
DK3030227T3
(da)
|
2013-08-07 |
2020-04-20 |
Incyte Corp |
Vedvarende frigivelses-doseringsformer for en jak1-inhibitor
|
|
CN107002119A
(zh)
|
2014-03-24 |
2017-08-01 |
豪夫迈·罗氏有限公司 |
使用c‑met拮抗剂的癌症治疗及前者与hgf表达的关联
|
|
SG11201608189WA
(en)
|
2014-04-03 |
2016-10-28 |
Merck Patent Gmbh |
Combinations of cancer therapeutics
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
MA40530A
(fr)
|
2014-08-27 |
2017-07-05 |
Prexton Therapeutics Sa |
Nouveau dérivé d'oxime de chromone et son utilisation comme modulateur allostérique de récepteurs métabotropiques du glutamate
|
|
JP6903585B2
(ja)
|
2015-03-13 |
2021-07-14 |
レスバーロジックス コーポレイション |
補体関連疾患の治療のための組成物および治療方法
|
|
SI3341380T1
(sl)
|
2015-08-27 |
2020-02-28 |
Prexton Therapeutics Sa |
Možgansko-penetranten derivat kromon oksima za terapijo levodopa-inducirane diskinezije
|
|
GB201516905D0
(en)
*
|
2015-09-24 |
2015-11-11 |
Stratified Medical Ltd |
Treatment of Neurodegenerative diseases
|
|
EP3260445A1
(en)
|
2016-06-24 |
2017-12-27 |
Universität Konstanz |
Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor
|
|
US10759865B2
(en)
|
2017-08-22 |
2020-09-01 |
Eyal Levit |
Treatment of diabetes mellitus
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
EP3502095A1
(en)
|
2017-12-22 |
2019-06-26 |
Universität Konstanz |
Compound for use against pathogenic neisseria and haemophilus species and moraxella catarrhalis
|
|
WO2019152374A1
(en)
|
2018-01-30 |
2019-08-08 |
Incyte Corporation |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
|
CA3095487A1
(en)
|
2018-03-30 |
2019-10-03 |
Incyte Corporation |
Treatment of hidradenitis suppurativa using jak inhibitors
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
AU2021376892A1
(en)
|
2020-11-16 |
2023-06-29 |
Merck Patent Gmbh |
Kinase inhibitor combinations for cancer treatment
|